Currently Viewing:
Patient-Centered Oncology Care
Currently Reading
Dr Thomas Graf: Personalizing Cancer Care Payment Models
April 16, 2018
Torrie Fields: Collecting and Using Data Can Better Inform a Patient
April 12, 2018
Dr Thomas Graf Discusses the Effect of Novel Therapies on Private Coverage
April 06, 2018
Kathleen Lokay: Incorporating the Latest Research and Supporting Physicians
April 05, 2018
Dr Stacey McCullough on the Pharmacist's Role in Patient Education
March 29, 2018
Dr Thomas Graf: How the Impact of Novel Therapies Varies Among Stakeholders
March 22, 2018
Jason Harris Highlights National Health Council's Recommendations on Real-World Evidence
March 18, 2018
Ian Manners Explains the Impact of Patient Financial Assistance Programs
March 17, 2018
Dr Thomas Graf on the Impact of New Therapies in Oncology
March 12, 2018
Jason Harris: Improving Patient Understanding and Promoting High-Value Care
March 02, 2018
Dr Brenton Fargnoli on Fixing Issues Physicians Have With EHRs
February 18, 2018
Kathleen Lokay: Implementing Value in Clinical Pathways
February 13, 2018
Jason Harris Discusses the Importance of Real-World Evidence
February 11, 2018
Dr Brenton Fargnoli Explains How Quality Measurement Benchmarks Drive Action
February 09, 2018
Kathleen Lokay on Educating Patients on Treatment Options
January 28, 2018
Dr Brenton Fargnoli Discusses the Creation of a Learning Health System
January 25, 2018
Kathleen Lokay on How Data Generation Informs Clinical Pathways
January 16, 2018
Torrie Fields: Data Collection Takes the Guesswork Out of Care
January 01, 2018
Kathleen Lokay: Clinical Pathways Can Prevent Prior Authorization Delays
December 24, 2017

Dr Thomas Graf: Personalizing Cancer Care Payment Models

Thomas Graf, MD, chief medical officer and vice president, Horizon Blue Cross Blue Shield of New Jersey, discusses evolving care bundle payments to better accommodate cancer patients.
 


Thomas Graf, MD, chief medical officer and vice president, Horizon Blue Cross Blue Shield of New Jersey, discusses evolving care bundle payments to better accommodate cancer patients.

Transcript

How can the patient-centered medical home model provide consistent high-quality care for patients, and how will novel therapies affect it?

In some sense, this isn’t a PCMH model. These patients aren’t being addressed by primary care doctors or family physicians. They are generally being treated by oncologists. One approach is the oncology medical home model, which is basically medical home for active cancer treatment patients, and that’s one approach to this, and CMS has found a way to incorporate new very expensive drug treatments into their model, which is helpful. I think the other approach that might be more amenable to this novel therapy issue are episodes of care bundled payment where we really focus on bundles and the delivery of care for a defined period. The challenge there is unlike heart failure or COPD or joint replacement, the variation from patient to patient, member to member, is significant.

Cancer, specifically lung cancer, is not a lung cancer is not a lung cancer. So, being able to precisely define the patient and understand the clinical differences that they have and create what we call precision models, maybe phenotypically driven, maybe more likely genotypically driven, or most likely a combination of both, will be critical. Instead of having one lung cancer bundle there might be a dozen depending on the type of treatments the patients need. Then, the patients that qualify or need or would get benefit from those high cost drugs could be included in that. For those that don’t, they would have a different price point per episode. That, I think is the beginning of the way forward. We have to wait and see how that turns out.

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!